Hikma Pharmaceuticals Plc 23 December 2024 Hikma Pharmaceuticals PLC (the "Company") LONDON, 23 December 2024: Hikma Pharmaceuticals PLC (LSE:...
Hikma Pharmaceuticals Plc 07 November 2024 Hikma Pharmaceuticals PLC Outcome of Audit Tender Process LONDON, 7 November 2024 - Hikma...
Hikma Pharmaceuticals PLC on Thursday said it is on track to deliver "another strong performance" following trading t ...
Hikma Pharmaceuticals Plc 07 November 2024 Hikma continues strong strategic execution and reiterates guidance London, 7 November 2024...
Hikma Pharmaceuticals Plc 24 October 2024 Hikma Pharmaceuticals PLC 2024 Annual General Meeting Update Statement LONDON, 24 October 2024...
Hikma Pharmaceuticals Plc 01 October 2024 Hikma Pharmaceuticals PLC Block Listing Six Monthly Return Date: 1 October 2024 Name of...
Hikma Pharmaceuticals Plc 24 September 2024 Hikma Pharmaceuticals PLC (the "Company") LONDON, 24 September 2024: Hikma Pharmaceuticals PLC...
Hikma Pharmaceuticals PLC announced on Tuesday it has completed its acquisition of the US finished dosage form busine ...
Hikma Pharmaceuticals Plc 10 September 2024 Hikma completes Xellia acquisition London, 10 September 2024 - Hikma Pharmaceuticals PLC (Hikma...
Berenberg on Tuesday upgraded Hikma Pharmaceuticals PLC to 'buy', highlighting an undemanding valuation and improved ...
Hikma Pharmaceuticals participates in naloxone training event with U.S. Congressman Buddy Carter ahead of...
KLOXXADO® 8mg Naloxone Nasal Spray Shelf-Life Extended from 24 months to 36 months PR Newswire LONDON, Aug...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Subscribe to Ad free and enjoy an ad-free experience
Try Now
Keep the Ads